Cheol Hee Lim

Title: Cheol Hee Lim: Innovator in Pharmaceutical Compositions

Introduction

Cheol Hee Lim is a prominent inventor based in Suwon-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds for medical applications. With a total of 4 patents to his name, Lim's work focuses on compounds that exhibit therapeutic potential.

Latest Patents

One of Lim's latest patents involves triazolones, tetrazolones, and imidazolones, or their salts, along with pharmaceutical compositions comprising these compounds. This technology provides preparation processes and uses for these compounds, which exhibit inhibitory activity on VAP-1. These compounds can be effectively applied for the treatment and prophylaxis of nonalcoholic hepatosteatosis (NASH). Another notable patent includes 3,3-difluoroallylamines or their salts, which also demonstrate potent inhibitory activity on VAP-1, making them useful for similar therapeutic applications.

Career Highlights

Cheol Hee Lim is associated with Yuhan Corporation, a leading pharmaceutical company in South Korea. His work at Yuhan Corporation has allowed him to focus on innovative research and development in the pharmaceutical sector. Lim's contributions have been instrumental in advancing the understanding and treatment of various medical conditions.

Collaborations

Lim has collaborated with notable colleagues, including Hee Jae Tak and Eun Kyung Kim. These collaborations have fostered a productive research environment, leading to significant advancements in their respective fields.

Conclusion

Cheol Hee Lim's innovative work in pharmaceuticals highlights his commitment to advancing medical science. His patents reflect a dedication to developing effective treatments for serious health conditions.